Should everyone with a recent myocardial infraction receive a beta-blocker and an ACE inhibitor?

Cleveland Clinic Journal of Medicine

Volumn 70, Issue 1, 2003, Pages 46-48

  Hostetter, John C ^a   Ghaffari, Sasan ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENALAPRILAT; ISOSORBIDE DINITRATE; LISINOPRIL; METOPROLOL; NITRIC OXIDE; PLACEBO; RAMIPRIL;

ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; ATRIOVENTRICULAR BLOCK; CARDIOGENIC SHOCK; CONTROLLED STUDY; CORONARY ARTERY DILATATION; COUGHING; DEATH; DRUG CONTRAINDICATION; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; DRUG USE; HEART AFTERLOAD; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE OXYGEN CONSUMPTION; HEART PRELOAD; HEART PROTECTION; HEART RATE; HUMAN; HYPOTENSION; INHIBITION KINETICS; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; MEDICAL SOCIETY; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PREGNANCY; RECEPTOR BINDING; RESPIRATORY TRACT DISEASE; UNITED STATES;

EID: 0037242028     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.70.1.46     Document Type: Article

References (7)

1. Braunwald E, Antman E, Beasley J, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. Circulation 2000; 102:1193-1209.
2. Dzau V. Mechanism of protective effects of ACE inhibition on coronary artery disease. Eur Heart J 1998; 19(suppl J):J2-J6.
3. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 1995; 345:669-682.
4. Swedberg K, Held P, Kjekshus J, et al. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med 1992; 327:678-684.
5. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. N Engl J Med 2000; 342:145-153.
6. Smith S, Blair S, Bonow R, et al. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. Circulation 2001; 104:1577-1579.
7. Pfeffer M, Domanski M, Verter J, et al. The Continuation of the Prevention of Events With Angiotensin-Converting Enzyme Inhibition (PEACE) trial. Am Heart J 2001; 142:375-377.